Trends Projected to Reshape the Healthcare Landscape in 2024
Several societal drivers will shape the healthcare landscape in 2024, including a longer-living population, transformative technologies, and global economic uncertainty. [...]
Novo Nordisk Joins Biopharma Companies Challenging Drug Price Negotiations in Inflation Reduction Act
Novo Nordisk and numerous other biopharma companies are challenging drug price negotiation provisions in the Inflation Reduction Act. Novo has [...]
2023 Nobel Prize in Medicine Awarded to mRNA Researchers Katalin Karikó and Drew Weissman
Katalin Karikó and Drew Weissman, two pioneers of mRNA research, were awarded the 2023 Nobel Prize in Medicine or Physiology [...]
Johnson & Johnson’s Drug Combination Improves Progression-Free Survival in Lung Cancer Trial Against AstraZeneca’s Therapy
The Mariposa study showed that a combination of two Johnson & Johnson (J&J) drugs, Rybrevant, and lazertinib, was successful in [...]
Integration of Digital Targeting in Addressable TV: Implications for Healthcare Marketers
Addressable TV—which uses digital targeting and measurements for television advertisements—is changing the marketing landscape. It allows healthcare marketers to reach [...]
Unveiling the NHS Data Landscape: First Comprehensive Mapping for Improved Transparency and Efficiency
Researchers from the Institute of Global Health Innovation at Imperial College London have mapped and evaluated all electronic data flows [...]
Roche Acquires Two RNA-Targeted Drug Programs for Alzheimer’s and Huntington’s from Ionis Pharmaceuticals
Roche has obtained two RNA-targeted drug programs for Alzheimer's and Huntington's diseases from Ionis Pharmaceuticals. The deal involves a $60 [...]
Galecto Laying Off 70% of Staff and Exploring Strategic Alternatives after Failed Lung Disease Drug Trial
Boston-based biotech firm Galecto plans to lay off 29 employees, approximately 70% of its workforce, after [...]
Class-Action Lawsuit Targets Johnson & Johnson and IBM after Data Breach
Johnson & Johnson and IBM face a proposed class-action lawsuit following a data breach at J&J’s [...]
GA4GH Announces Ten New International Genomic Data Initiatives
The Global Alliance for Genomics and Health (GA4GH) has announced ten new international genomic data initiatives, [...]
Risk of Long Covid Increases with Each COVID-19 Reinfection, Indicates Study
The coronavirus pandemic has prompted questions about reinfection and the risk of developing "long Covid" characterized [...]
California Legislature Approves Bills for 10,000 New Beds and Expanded Drug Addiction Treatment to Address Homelessness and Drug Crises
The California Legislature has approved two bills that aim to address the state's homelessness and drug [...]
Polio Eradication Goals for 2023 Likely To Be Missed: Insights from the Independent Monitoring Board
According to a report by the polio program's Independent Monitoring Board, the Global Polio Eradication Initiative [...]
Adapting to Challenges and Opportunities: Medical Device Makers in a Tightening Economy
In today's tightening economy, medical device makers face more hurdles with the dwindling post-COVID-19 investment boom [...]
FDA Approves Updated Covid-19 Booster Shots from Pfizer/BioNTech and Moderna
The FDA has approved updated Covid-19 booster shots from Pfizer/BioNTech and Moderna for the fall season. The CDC's vaccine advisors [...]
Major Transformations Expected in Clinical Trials Industry with Projected Growth to USD 73.2 Billion by 2028
The clinical trials industry is predicted to evolve significantly, with advancements in technology like AI, machine learning, and blockchain that [...]
Seagen and Nurix Partner to Develop New Cancer Therapy, Deal Could Reach $3.4 Billion
Seattle-based biotech Seagen will partner with Nurix to develop degrader-antibody conjugates (DACs), a new type of cancer therapy. Seagen is [...]
Astellas Drops Lawsuit Against HHS Following Exclusion of Xtandi from Drug Price Negotiation List
Astellas has canceled its lawsuit against the U.S. Department of Health and Human Services (HHS) after its prostate cancer drug, [...]
Healthcare Sector Experiences Fluctuating Fund Flows
Top 10 Things You Need to Know: Healthcare is often seen as a defensive sector due to its constant demand [...]
Shortening Mental Health Treatment Waiting Times Could Save NHS Millions and Improve Patient Outcomes
What You Need to Know: Shortening treatment and waiting times for mental health conditions from 12 months to three could [...]
Novo Nordisk’s Obesity Drugs Reshape Denmark’s Economy, Sparking Economic and Policy Debates
Novo Nordisk, a Danish firm initially known for producing diabetes drugs, has become highly influential on Denmark's economy due to [...]
FDA Releases Guidance on Utilizing Real-World Evidence for Pharmaceutical Regulatory Review Process
The FDA has published final draft guidance for pharmaceutical companies, indicating how they can use real-world evidence to support their [...]
Healthcare Data Market Forecasted to Triple by 2030 Amidst Real-World Evidence Boom
The mass digitization of healthcare records has created a wealth of clinical data assets, leading to a predicted 14.6% growth [...]
Mallinckrodt Files for Second Bankruptcy; Plans $1 Billion Debt Reduction Amid Opioid Litigation
Drugmaker Mallinckrodt has filed for its second bankruptcy in the US within three years, with a restructuring plan aiming to [...]
Medicare to Negotiate Prices for 10 High-Cost Drugs Under New Democratic Reform Law
Medicare will negotiate prices for ten high-cost drugs, including major diabetes medications and blood thinners, as part of a drug [...]